Medications for opioid use disorder (MOUD) are one of the most effective routes to recovery for individuals with opioid use disorder. HCS communities implemented a variety of practices to increase access and acceptance of MOUD, which include buprenorphine, methadone, and naltrexone. All these medications have received FDA approval for OUD treatment and have helped individuals sustain long-term recovery.
Here, we provide resources about strategies to raise awareness and increase availability of MOUD in your community.
Dr. John Winhusen, Professor at University of Cincinnati College of Medicine and HCS principal investigator, explains how medication for opioid use disorder (MOUD) work, their effectiveness, and debunks common myths about MOUD.
Courtesy of HEAL Connections
How to use the 72-hour methadone rule to administer methadone to patients in opioid withdrawal.
How to add or expand the availability of long-acting injectable buprenorphine in primary care, behavioral health, specialty substance use disorder, and recovery program settings.
This quick guide explains the benefits of community "bridge" clinics. Bridge clinics expand access to methadone by treating opioid withdrawal with methadone for up to 72 hours and providing rapid referrals to outpatient treatment programs.
Starting medications for the treatment of opioid use disorder during hospitalization is associated with a reduction in substance use, improved treatment retention, and decreased hospital readmission. This guide instructs hospital administrators and staff on how to add or expand addiction consultation services.
This video provides an overview of methadone and addresses some common myths clients might hear about methadone use.
This manual provides resources used to train recovery coaches to implement programs that help individuals link to and stay retrained in MOUD treatment.
Learn about methadone, including answers to common questions or addressing commonly heard methadone myths.
This facts sheet corrects and clarifies common misconceptions about taking MOUD during pregnancy and postpartum.
This is a comprehensive training manual for two care navigation programs for delivering MOUD linkage and retention services created by HCS researchers in Kentucky in partnership with Bluegrass Care Navigators.
People who start medication for opioid use disorder (MOUD) prior to release from jail or prison and continue taking MOUD as they reenter their communities are 75% less likely to experience an overdose. Learn about a program championed by the sheriff’s department and community partners in Hamilton County, Ohio, which ensures incarcerated individuals can access treatment prior to release.
Providing emergency housing to support entry into and reentry from treatment for opioid use disorder: A behavioral health and law enforcement crisis responses team collaboration in Ulster County, New York.